APNAspen Pharmacare HoldingsAPN info
$13.23info1.67%24h
Global rank2464
Market cap$5.88B
Change 7d-0.87%
YTD Performance18.93%
SP500 benchmarkOutperform
P/E0
P/S2.57
Revenue$2.28B
Earnings$293.12M
Dividend yield-
Main Sector
Healthcare

Aspen Pharmacare Holdings (APN) Stock Overview

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

APN Stock Information

Symbol
APN
Address
Aspen PlaceDurban, South Africa
Founded
-
Trading hours
-
Website
https://www.aspenpharma.com
Country
πŸ‡ΏπŸ‡¦ South Africa
Phone Number
27 31 580 8600

Aspen Pharmacare Holdings (APN) Price Chart

-
Value:-

Aspen Pharmacare Holdings Overview: Key Details and Summary

Stock data
2023
Change
Price
$13.23
N/A
Market Cap
$5.88B
N/A
Shares Outstanding
444.24M
-1.93%
Employees
8.61K
N/A
Shareholder Equity
86.24B
21.56%
Valuation
2023
Change
P/S Ratio
2.57
N/A
P/B Ratio
0.07
N/A
Growth
2023
Change
Return on Equity
0.0034
N/A
Earnings
2023
Change
Revenue
$2.28B
N/A
Earnings
$293.12M
N/A
Gross Margin
0.4522
N/A
Operating Margin
0.2197
N/A
Net income margin
0.1284
N/A
Financial Strength
2023
Change
Total Assets
$7.53B
N/A
Total Debt
$1.64B
N/A
Cash on Hand
$611.80M
N/A
Debt to Equity
0.0312
-2.24%
Cash to Debt
0.3727
34.08%
Current Ratio
$1.92
30.13%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org